Back to Article
Drug-Receptor Interaction of Peptidic HIV-1 Protease: Intermolecular Interaction-III
Online Journal of Microbiological Research
| Vol 3, Issue 1
Table 5. Classification of compounds (acid/A or base/B) withrespect to receptor amino acids
| No. | χD | Val | Ile | No. | χD | Val | Ile |
| χR =4.71 | χR =4.88 | χR =4.71 | χR =4.88 | ||||
| 1 | 4.97 | A | A | 27 | 5.47 | A | A |
| 2 | 5.01 | A | A | 28 | 4.97 | A | A |
| 3 | 5.36 | A | A | 29 | 4.74 | A | B |
| 4 | 5.01 | A | A | 30 | 4.92 | A | A |
| 5 | 4.98 | A | A | 31 | 4.93 | A | A |
| 6 | 5.02 | A | A | 32 | 5.16 | A | A |
| 7 | 5.06 | A | A | 33 | 5.10 | A | A |
| 8 | 5.34 | A | A | 34 | 5.19 | A | A |
| 9 | 4.94 | A | A | 35 | 4.88 | A | A |
| 10 | 5.33 | A | A | 36 | 4.96 | A | A |
| 11 | 4.93 | A | A | 37 | 4.89 | A | A |
| 12 | 5.37 | A | A | 38 | 4.89 | A | A |
| 13 | 5.03 | A | A | 39 | 4.85 | A | B |
| 14 | 5.33 | A | A | 40 | 4.90 | A | A |
| 15 | 4.97 | A | A | 41 | 4.99 | A | A |
| 16 | 5.12 | A | A | 42 | 4.94 | A | A |
| 17 | 5.33 | A | A | 43 | 4.87 | A | B |
| 18 | 4.92 | A | A | 44 | 4.95 | A | A |
| 19 | 4.90 | A | A | 45 | 4.83 | A | B |
| 20 | 4.93 | A | A | 46 | 4.82 | A | B |
| 21 | 5.02 | A | A | 47 | 4.89 | A | A |
| 22 | 5.17 | A | A | 48 | 4.80 | A | B |
| 23 | 4.88 | A | A | 49 | 4.90 | A | A |
| 24 | 5.40 | A | A | 50 | 4.99 | A | A |
| 25 | 4.84 | A | B | 51 | 4.97 | A | A |
| 26 | 4.53 | B | B | ||||
χ: electronegativity, R: receptor amino acid, D stand for drug (HIV-1-PRIs), Val: valine, Ile: isoleucine, A: acid and B: base.